OSCEOLA, WI--(Marketwire - September 27, 2011) -
In an effort to help healthcare practitioners streamline their practice and Navigate the Maze to Optimal Health™, NeuroScience, Inc.
, the leader in neurotransmitter testing, introduces the NEI Certification program
This program is designed to facilitate the integration of the Neuro-Endo-Immune (NEI) Supersystem© concept into practitioners' health management approach. NeuroScience's founder and CEO, Dr. Gottfried Kellermann, states: "This concept recognizes that a patient's health status is the result of imbalances in more than one system. Healthcare practitioners who adopt the NEI concept find their patients have better long-term clinical outcomes."
"NeuroScience's neurotransmitter, hormone, and immune tests allow me to discover root causes of symptoms and conditions that would otherwise take months to uncover using previous diagnostic methods," notes Dr. David Stewart, M.D. of Leesburg, VA. "Therefore, I am able to save my patients time and money while improving their quality of life in a significant way."
The core curriculum of the NEI Certification program focuses on neurology and neurotransmitter testing. It consists of 14 voice-narrated, self-paced online modules with topics including:
- Nervous system anatomy and physiology
- Case studies using neurotransmitter testing
Upon successful completion of the core curriculum, the healthcare practitioner earns NEI Certification, which comes with several benefits. To learn more, visit www.neuroscienceinc.com/neicertification.
This program is free and available to healthcare practitioners who are customers of NeuroScience, Inc. Future offerings will include endocrine- and immune-focused curricula, as well as specialty topics including nutritional supplements and advanced case studies.
About NeuroScience, Inc.:
NeuroScience, Inc, established in 1999, is devoted to medical solutions that improve health by providing novel laboratory assessments and products in the emerging field of Neuro-Endo-Immunology (NEI). The company is research and education-focused and has a database that includes results from over 500,000 patients.